中国药业2012，Vol.21Issue(24)：15-16,2.
α-葡萄糖苷酶抑制剂专利文献分析及其中药源新药开发进展
Patent Literature Analysis of α - Glucosidase Inhibitor and Development Progress on Its Chinese Medicinal New Drug
姚虹1
作者信息
- 1. 上海医药高等专科学校,上海,201318;上海交通大学医学院附属卫生学校,上海,201318
- 折叠
摘要
Abstract
α-glucosidase inhibitor is a new oral hypoglycemic drug researched and developed in the late 1970s,with mild and persistent effect, little side - effect, even non - toxicity, which is one of the hot points of diabetic pharmacotherapy in recent years. The Chinese herbal medicine as the Chinese characteristics drug resource is becoming the new drug research way,it is our characteristics research to find a - glucosidase inhibitor from Chinese medicine. Patent is the key intellectual property and technical literature in the process of new drug development. By analyzing the relevant Chinese patents and literature, the development status quo of Chinese medicinal new drug of α - glucosidase is reviewed.关键词
α-葡萄糖苷酶抑制剂/专利/新药/中药Key words
α- glucosidase inhibitor/patent/new drug/Chinese medicine分类
医药卫生引用本文复制引用
姚虹..α-葡萄糖苷酶抑制剂专利文献分析及其中药源新药开发进展[J].中国药业,2012,21(24):15-16,2.
